Uncovering the Mechanisms of PFAS-induced Immunotoxicity
揭示 PFAS 诱导免疫毒性的机制
基本信息
- 批准号:10115847
- 负责人:
- 金额:$ 9.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-28 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AcidsAdaptive Immune SystemAddressAffectAirAnimal ModelAnimalsAntibodiesAntibody FormationAntigensB-Cell DevelopmentB-LymphocytesBioenergeticsBiologicalBiological AssayBiomedical ResearchCause of DeathCell LineCell physiologyCellsChemical StructureChemicalsChemotaxisChronic DiseaseCommunitiesDataDepositionDermalDevelopmentDiseaseEmbryoEnvironmentEnvironmental HealthEnvironmental PollutionEnvironmental Risk FactorEventExperimental Animal ModelExposure toFlow CytometryFoodFrequenciesFutureGoalsHazardous SubstancesHealthHepatotoxicityHumanHuman Cell LineImmuneImmune System DiseasesImmune responseImmune systemImmunizeImmunosuppressionImmunotherapyImpairmentIn VitroIndividualIndustrial ProductIndustrializationInfectionInnate Immune SystemKnowledgeMalignant NeoplasmsMeasuresMediatingMetabolicMetabolismMitochondriaModelingMolecularMusNatural ImmunityNorth CarolinaOrganismOutcomePhagocytesPhagocytosisPlasma CellsProductionPublic HealthReactive Oxygen SpeciesResearchResearch Project GrantsResistanceRespirationRiskSamplingSerumSignal PathwaySignaling ProteinSiteSourceStainsSuperfundT-LymphocyteTestingToxic effectToxicologyUnited StatesUniversitiesWaterWorkZebrafishadaptive immunitybasebioaccumulationconsumer productdevelopmental toxicitydisorder riskdrinking waterexperienceexposed human populationhazardimmune functionimmune healthimmunoregulationimmunotoxicityimprovedin vivoin vivo Modelmacrophagemetabolomemetabolomicsmouse modelneutrophilnovelperfluorooctane sulfonateprogramsrapid techniquereproductive toxicityresponsetooltranscriptomevaccine response
项目摘要
ABSTRACT
(Biomedical Research) Research Project 2
Biomedical Research Project 2 is one of two biomedical research projects proposed for the “Center for
Environmental and Health Effects of PFAS” being led by North Carolina State University (NC State). The primary
goal of the proposed Center is to provide highly relevant data and information to help the Superfund Research
Program (SRP) address the growing problem of per- and polyfluoroalkyl substance (PFAS) contamination across
the United States (US). PFAS are considered contaminants of emerging concern for myriad reasons, but one of
the most pressing is that only a handful of the nearly 5,000 PFAS that are known to exist have been evaluated
for their toxicologic potential, even though numerous communities are being impacted by their presence in
environmental media, especially drinking water. Studies of humans exposed to perfluoroocatonic acid (PFOA)
and perfluorooctane sulfonate (PFOS), two PFAS detected with high frequency and concentration in human and
environmental samples, have provided compelling evidence that the immune system is a sensitive target of
PFAS. Additional work with experimental animal models supports the hypothesis that PFAS induce
immunotoxicity and alter responses of both the adaptive and innate immune systems. While PFOA and PFOS
are presumed to be immune hazards to humans, several gaps in knowledge exist: notably, the mechanism(s)
by which these PFAS induce immunotoxicity remain elusive, and the extent to which most PFAS of emerging
concern perturb immune function is largely unknown. Therefore, the objectives of Project 2 are twofold: i) explore
molecular changes underlying PFAS-induced immunotoxicity in select animal models as well as human cell lines
to identify impacted signaling pathways and networks, and ii) determine the immunotoxicological profile,
including mechanistic underpinnings, of PFAS of emerging concern relative to the few well-studied PFAS. Our
global hypothesis is that PFAS-mediated immune suppression results from modulation of immune cell metabolic
functions. This hypothesis will be evaluated by (Aim 1) quantifying the impact of PFAS exposure on B cell
development and antibody production in a mouse model and (Aim 2) identifying the impact of PFAS exposure
on phagocytotic cell function using a zebrafish in vivo model and human in vitro cell line models. This project will
address significant gaps in what is known about the mechanisms by which PFAS induce immunotoxicity, which
will improve management of a known PFAS health risk, immune suppression, and accelerate development of
immune therapies for affected individuals. Additionally, the large number of untested PFAS also means that
methods for rapid prioritization are critical for informing appropriate regulatory measures; our project will uncover
molecular initiating events underlying altered immune responses to facilitate novel, immune-mechanism-based
prioritization strategies for PFAS recently detected in North Carolina and elsewhere.
抽象的
(生物医学研究)研究项目2
生物医学研究项目2是为“中心”提出的两个生物医学研究项目之一
PFAS 的环境和健康影响”由北卡罗来纳州立大学(北卡罗来纳州)领导。
拟议中心的目标是提供高度相关的数据和信息,以帮助超级基金研究
计划 (SRP) 解决了日益严重的全氟烷基物质和多氟烷基物质 (PFAS) 污染问题
由于多种原因,美国 (US) 认为 PFAS 是新出现的污染物,但其中之一是。
最紧迫的是,已知存在的近 5,000 种 PFAS 中,只有少数经过评估
由于其毒理学潜力,尽管许多社区正受到其存在的影响
环境介质,特别是饮用水中的人类接触全氟辛酸 (PFOA) 的研究。
和全氟辛烷磺酸 (PFOS),这两种 PFAS 在人体和人体中检测到的频率和浓度较高
环境样本提供了令人信服的证据,表明免疫系统是免疫系统的敏感目标
PFAS。对实验动物模型的额外研究支持了 PFAS 诱导的假设。
PFOA 和 PFOS 具有免疫毒性并改变适应性和先天免疫系统的反应。
被认为对人类有免疫危害,但存在一些知识空白:值得注意的是,其机制
这些 PFAS 是如何引起免疫毒性的仍然难以捉摸,而且大多数新兴的 PFAS 在多大程度上会引起免疫毒性?
扰乱免疫功能的问题在很大程度上是未知的,因此,项目 2 的目标有两个:i) 探索。
PFAS 在特定动物模型以及人类细胞系中诱导免疫毒性的分子变化
确定受影响的信号通路和网络,以及 ii) 确定免疫毒理学特征,
与少数经过充分研究的 PFAS 相比,PFAS 的新兴关注点包括其机制基础。
总体假设是 PFAS 介导的免疫抑制是免疫细胞代谢调节的结果
该假设将通过(目标 1)量化 PFAS 暴露对 B 细胞的影响来评估。
在小鼠模型中进行发育和抗体生产,并(目标 2)确定 PFAS 暴露的影响
该项目将使用斑马鱼体内模型和人类体外细胞系模型来研究吞噬细胞功能。
解决了 PFAS 诱导免疫毒性机制已知的重大空白,
将改善对已知 PFAS 健康风险、免疫抑制的管理,并加速开发
此外,大量未经测试的 PFAS 也意味着
快速确定优先级的方法对于告知适当的监管措施至关重要;
分子起始事件改变了潜在的免疫反应,以促进基于免疫机制的新型免疫反应
最近在北卡罗来纳州和其他地方发现的 PFAS 优先策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Seth William Kullman其他文献
Seth William Kullman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Seth William Kullman', 18)}}的其他基金
Uncovering the Mechanisms of PFAS-induced Immunotoxicity
揭示 PFAS 诱导免疫毒性的机制
- 批准号:
10559567 - 财政年份:2022
- 资助金额:
$ 9.71万 - 项目类别:
Uncovering the Mechanisms of PFAS-induced Immunotoxicity
揭示 PFAS 诱导免疫毒性的机制
- 批准号:
10558142 - 财政年份:2020
- 资助金额:
$ 9.71万 - 项目类别:
Uncovering the Mechanisms of PFAS-induced Immunotoxicity
揭示 PFAS 诱导免疫毒性的机制
- 批准号:
10337308 - 财政年份:2020
- 资助金额:
$ 9.71万 - 项目类别:
In vivo Transgenic Reporter for Hepatobiliary Toxicity
肝胆毒性的体内转基因报告基因
- 批准号:
6940651 - 财政年份:2004
- 资助金额:
$ 9.71万 - 项目类别:
In vivo Transgenic Reporter for Hepatobiliary Toxicity
肝胆毒性的体内转基因报告基因
- 批准号:
6840566 - 财政年份:2004
- 资助金额:
$ 9.71万 - 项目类别:
Molecular Pathways to Pathogenesis in Toxicology
毒理学发病机制的分子途径
- 批准号:
10172421 - 财政年份:1977
- 资助金额:
$ 9.71万 - 项目类别:
Molecular Pathways to Pathogenesis in Toxicology
毒理学发病机制的分子途径
- 批准号:
10452637 - 财政年份:1977
- 资助金额:
$ 9.71万 - 项目类别:
Molecular Pathways to Pathogenesis in Toxicology
毒理学发病机制的分子途径
- 批准号:
10626916 - 财政年份:1977
- 资助金额:
$ 9.71万 - 项目类别:
相似海外基金
Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
- 批准号:
10626281 - 财政年份:2023
- 资助金额:
$ 9.71万 - 项目类别:
Assembly and re-alignment of HLA genomic region and its implication for fine-mapping suicidality in African descent population
HLA基因组区域的组装和重新排列及其对非洲人后裔自杀倾向精细定位的意义
- 批准号:
10797122 - 财政年份:2023
- 资助金额:
$ 9.71万 - 项目类别:
Autoimmune Drivers and Protectors Team Science (ADAPTS)
自身免疫驱动器和保护器团队科学 (ADAPTS)
- 批准号:
10657232 - 财政年份:2023
- 资助金额:
$ 9.71万 - 项目类别:
Spacer acquisition during the type III-A CRISPR-Cas immune response
III-A 型 CRISPR-Cas 免疫反应期间间隔区的获取
- 批准号:
10638980 - 财政年份:2023
- 资助金额:
$ 9.71万 - 项目类别:
PGI2 restrains immunopathogenesis in hypertension
PGI2 抑制高血压的免疫发病机制
- 批准号:
10731402 - 财政年份:2023
- 资助金额:
$ 9.71万 - 项目类别: